Right ventricle-specific therapies in acute respiratory distress syndrome: a scoping review
- PMID: 36907888
- PMCID: PMC10008150
- DOI: 10.1186/s13054-023-04395-9
Right ventricle-specific therapies in acute respiratory distress syndrome: a scoping review
Abstract
Objective: To summarize knowledge and identify gaps in evidence regarding treatment of right ventricular dysfunction (RVD) in acute respiratory distress syndrome (ARDS).
Data sources: We conducted a comprehensive search of MEDLINE, Embase, CINAHL, Web of Science, and the Cochrane Central Register of Controlled Trials.
Study selection: Studies were included if they reported effects of treatments on right ventricular function, whether or not the intent was to modify right ventricular function.
Data extraction: Data extraction was performed independently and in duplicate by two authors. Data items included the study design, patient population, type of intervention, comparison group, and RV-specific outcomes.
Data synthesis: Of 1,430 studies screened, 51 studies reporting on 1,526 patients were included. By frequency, the included studies examined the following interventions: ventilator settings (29.4%), inhaled medications (33.3%), extracorporeal life support (13.7%), intravenous or oral medications (13.7%), and prone positioning (9.8%). The majority of the studies were non-randomized experimental studies (53%), with the next most common being case reports (16%). Only 5.9% of studies were RCTs. In total, 27% of studies were conducted with the goal of modifying RV function.
Conclusions: Given the prevalence of RVD in ARDS and its association with mortality, the dearth of research on this topic is concerning. This review highlights the need for prospective trials aimed at treating RV dysfunction in ARDS.
Keywords: ARDS; Right ventricular dysfunction; Scoping review; Treatment.
© 2023. The Author(s).
Conflict of interest statement
The authors have no financial or non-financial competing interests to report.
Figures
Comment in
-
Right ventricule-specific therapies in ARDS: other vasodilating agents to be considered.Crit Care. 2023 Apr 3;27(1):133. doi: 10.1186/s13054-023-04419-4. Crit Care. 2023. PMID: 37013621 Free PMC article. No abstract available.
References
-
- Sato R, Dugar S, Cheungpasitporn W, Schleicher M, Collier P, Vallabhajosyula S, et al. The impact of right ventricular injury on the mortality in patients with acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care. 2021;25(1):172. doi: 10.1186/s13054-021-03591-9. - DOI - PMC - PubMed
-
- Mekontso Dessap A, Boissier F, Charron C, Bégot E, Repessé X, Legras A, et al. Acute cor pulmonale during protective ventilation for acute respiratory distress syndrome: prevalence, predictors, and clinical impact. Intensive Care Med. 2016;42(5):862–870. doi: 10.1007/s00134-015-4141-2. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources